Emergency Use Authorization for Lilly's bamlanivimab and etesevimab administered together expanded to include post-exposure prophylaxis for COVID-19

Expanded emergency use authorization includes certain people who have been exposed to someone infected with SARS-CoV-2 or who are at high risk of exposure in an institutional setting INDIANAPOLIS, Sept. [...]